SCHEMBL7544949

SCHEMBL7544949

CC(C)CCN(C(=O)c1ccc(-c2csc(N3CCN(C(=O)O)CC3)n2)cc1)C(=O)N(C)C#N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
MAPT P10636 5/20 0.46
LMNA P02545 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPK1 P28482 3/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HTT P42858 2/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CTSL P07711 5/20 0.41
CTSB P07858 5/20 0.41
CTSS P25774 5/20 0.41
HSD17B10 Q99714 1/20 0.40
CTSK P43235 3/20 0.40
KDM4E B2RXH2 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7586301 0.90 MAPT (0.56) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL7588285 0.89 MAPT (0.45) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL7536935 0.84 CTSB (0.49) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL6183250 0.80 MAPT (0.44) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL6182191 0.78 MAPT (0.55) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL6183082 0.77 CTSS (0.46) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL6183359 0.76 ENPP2 (0.46) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL7586450 0.76 GPR119 (0.41)
SCHEMBL6182283 0.75 CTSB (0.44) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL6183637 0.74 PARP1 (0.51) MAPTLMNASMN1; SMN2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001068645-A2 N-CYANOMETHYLCARBOXAMIDES AND THEIR USE AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-09-20 WO disclosed